BioMarin Pharmaceutical Inc. buy Wells Fargo & Company
Start price
28.10.25
/
50%
€46.07
Target price
28.10.26
€60.05
Performance (%)
2.08%
Price
14.04.26
€47.03
Summary
This prediction is currently active. With a performance of 2.08%, the BUY prediction by Wells_Fargo___Compan for BioMarin Pharmaceutical Inc. is trending in the right direction. This prediction currently runs until 28.10.26. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| BioMarin Pharmaceutical Inc. | -3.031% | -3.031% |
| iShares Core DAX® | 3,02 % | 2,20 % |
| iShares Nasdaq 100 | 3,56 % | 1,33 % |
| iShares Nikkei 225® | 6,62 % | 5,71 % |
| iShares S&P 500 | 2,64 % | 1,01 % |
Comments by Wells_Fargo___Compan for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical (NASDAQ:BMRN) had its price target lowered by analysts at Wells Fargo & Company from $90.00 to $70.00. They now have an "overweight" rating on the stock.
Ratings data for BMRN provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€51.10
18.02.26
18.02.26
€63.32
18.02.27
18.02.27
-7.96%
14.04.26
14.04.26
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€64.04
17.09.24
17.09.24
€80.92
17.09.25
17.09.25
-27.97%
18.09.25
18.09.25
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€77.46
27.06.24
27.06.24
€107.36
27.06.25
27.06.25
-39.27%
28.06.25
28.06.25
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€77.00
25.04.24
25.04.24
€102.63
25.04.25
25.04.25
-27.92%
26.04.25
26.04.25
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€80.32
15.11.23
15.11.23
€92.05
15.11.24
15.11.24
-24.98%
16.11.24
16.11.24